Prolonged antibiotic treatment durations for community-onset infections in Dutch hospitals

Sharon E J D van den Eijnde1,2, Jesper van Breeschoten3, Jurjen S Kingma4

  • 1Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, Netherlands.

Abstract

Insights

Prolonged antibiotic use is common, especially for respiratory infections in Dutch hospitals. Identifying risk factors can help antibiotic stewardship programs optimize prescribing and reduce unnecessary treatment durations.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Hospital Administration

Background:

  • Antibiotic stewardship programs (ASPs) are crucial for optimizing antibiotic use.
  • Prolonged antibiotic therapy increases risks of adverse events, antimicrobial resistance, and healthcare costs.
  • This study investigated the prevalence and risk factors of prolonged antibiotic treatment for community-onset infections in Dutch hospitals.

Purpose of the Study:

  • To determine the period prevalence of prolonged antibiotic treatment durations for common community-onset infections.
  • To identify specific risk factors associated with prolonged antibiotic use in hospitalized patients.
  • To inform strategies for improving antibiotic prescribing practices within Dutch healthcare settings.

Main Methods:

  • Retrospective cohort study of adult patients in four Dutch hospitals (2021-2023).
  • Inclusion criteria: admission ≥12 hours, antibiotic treatment within 48 hours.
  • Analysis included linking prescriptions to diagnoses, comparing therapy length to national guidelines, and logistic regression for risk factor identification.

Main Results:

  • 30% of 9,878 admissions received prolonged antibiotic treatment.
  • Respiratory tract infections (RTIs) showed the highest prevalence (49.6%), particularly community-acquired pneumonia (51.0%) and aspiration pneumonia (55.9%).
  • Risk factors included positive cultures, IV-to-oral switch, specific RTI diagnoses (pneumonia), and cystitis in UTIs.

Conclusions:

  • A significant prevalence of prolonged antibiotic treatment was observed, especially for RTIs.
  • Identified risk factors can guide ASPs in refining antibiotic prescribing protocols.
  • Reducing non-guideline-concordant therapy is essential for antimicrobial stewardship.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
138
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
85
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
832
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
422
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
211